EV
Eric Venker sold $7.6M of ROIV stock
Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd. (ROIV), sold 187,943 shares of ROIV stock worth $7.6M, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 10, 2026, 3 days before it was made public.
ROIV has moved -4.0% since the trade date, from $41.19 to $39.53 (Nov 13, 2026 close).
- Traded
- Nov 10, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 3 days
- Price since
- -4.0%
- Role
- President & Immunovant CEO
- Source
- SEC Form 4